Empagliflozin increases plasma levels of campesterol, a marker of cholesterol absorption, in patients with type 2 diabetes: Association with a slight increase in high-density lipoprotein cholesterol-Reference-Cited by-同舟云学术

Empagliflozin increases plasma levels of campesterol, a marker of cholesterol absorption, in patients with type 2 diabetes: Association with a slight increase in high-density lipoprotein cholesterol

Published:2021-05 Issue: Volume:331 Page:243-248
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Jojima Teruo,Sakurai Shintaro,Wakamatsu Sho,Iijima Toshie,Saito Masahiro,Tomaru Takuya,Kogai Takahiko,Usui Isao,Aso Yoshimasa

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N. Engl. J. Med.,2015

2. Canagliflozin and cardiovascular and renal events in type 2 diabetes;Neal;N. Engl. J. Med.,2017

3. Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis;Zaccardi;Diabetes Obes. Metab.,2016

4. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials;Zelniker;Lancet.,2019

5. Dyslipidemia in type 2 diabetes mellitus;Mooradian;Nat. Clin. Pract. Endocrinol. Metab.,2009

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Validation and Determination of Empagliflozin Concentration in the Presence of Grapefruit Juice Using HPLC for Pharmacokinetic Applications;Molecules;2024-03-11

2. Drug Safety Evaluation of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Comorbid Patients by Review of Systemic Extraglycemic Effects;Diabetes, Metabolic Syndrome and Obesity;2024-03

3. Development and validation of Empagliflozin and Linagliptin simultaneous estimation in rat plasma using freezing lipid precipitation and SCX-SPE assisted HPLC–MS/MS method and its application in pharmacokinetic studies;Analytical Sciences;2023-11-03

4. SGLT-2 Inhibitors: The Next-generation Treatment for Type 2 Diabetes Mellitus;Current Medicinal Chemistry;2023-10-19

5. Evaluation Cholesterol and Triglycerides Levels for Type One Diabetes Patients;World Journal of Current Medical and Pharmaceutical Research;2023-09-19